96 related articles for article (PubMed ID: 6174393)
21. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and monitoring of endangered early pregnancies with determination of oestrone, oestradiol 17beta, oestriol, progesterone and HPL in plasma and the pregnancy test in graduated dilutions of urine (author's transl)].
Strecker JR; Negulescu R; Dahlén H; Musch K
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):509-15. PubMed ID: 885322
[TBL] [Abstract][Full Text] [Related]
23. Alpha-fetoprotein: a review.
Crandall BF
Crit Rev Clin Lab Sci; 1981; 15(2):127-85. PubMed ID: 6169490
[TBL] [Abstract][Full Text] [Related]
24. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
Milunsky A; Alpert E; Neff RK; Frigoletto FD
Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
26. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
27. Effect of chorionic villus sampling on serum alpha fetoprotein levels.
Edersheim TG; Thornton YS; Alonso ML; Kazam E
Am J Perinatol; 1985 Oct; 2(4):328-9. PubMed ID: 2413871
[TBL] [Abstract][Full Text] [Related]
28. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
29. Utility of the triple test in the detection of abnormalities of the feto-placental unit.
Perenc M; Dudarewicz L; Kałuzewski B
Med Sci Monit; 2000; 6(5):994-9. PubMed ID: 11208444
[TBL] [Abstract][Full Text] [Related]
30. [Early amniocentesis between the 12th-14th week of pregnancy. Clinical experiences with 1,100 cases].
Eiben B; Goebel R; Rutt G; Jaspers KD; Hansen S; Hammans W
Geburtshilfe Frauenheilkd; 1993 Aug; 53(8):554-8. PubMed ID: 7690727
[TBL] [Abstract][Full Text] [Related]
31. [Alpha-1 fetoprotein in maternal serum (author's transl)].
Melchert F
Geburtshilfe Frauenheilkd; 1975 Mar; 35(3):173-6. PubMed ID: 48489
[TBL] [Abstract][Full Text] [Related]
32. [Radioimmunoassay of HCG and HCG beta in blood during pregnancy and trophoblastomas].
Mputu L; Thomas K; Renaer M; Vorstermans M; de Muylder X; Ferin J
J Gynecol Obstet Biol Reprod (Paris); 1977 Sep; 6(6):777-91. PubMed ID: 199644
[TBL] [Abstract][Full Text] [Related]
33. [The behavior of serum hCG level in normal and disordered pregnancy--a prognostic factor].
Arsenow H; Dericks-Tan JS; Taubert HD
Zentralbl Gynakol; 1991; 113(11):633-8. PubMed ID: 1927109
[TBL] [Abstract][Full Text] [Related]
34. Maternal serum free beta-hCG levels in uncomplicated pregnancies at the 10th-15th week of gestation and the development of obstetric complications.
De León J; Sifuentes G; Hopkins C; Noble V; Gimpel T; Myles T; Santolaya-Forgas J
J Reprod Med; 2004 Feb; 49(2):89-92. PubMed ID: 15018435
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of a single antibody RIA assay for alpha-fetoprotein.
Needleman SB; Goldstein AI; Johnson AM; Golubjatnikov R; Ward AM; Fifield R
J Reprod Med; 1980 Sep; 25(3):101-7. PubMed ID: 6159471
[TBL] [Abstract][Full Text] [Related]
36. [Maternal alpha-fetoprotein. Its levels in the eluate of dried blood for screening antenatally defects in the closure of the neural tube (author's transl)].
Travert G; Herlicoviez M
J Gynecol Obstet Biol Reprod (Paris); 1980; 9(5):537-41. PubMed ID: 6161152
[TBL] [Abstract][Full Text] [Related]
37. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
38. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
Gerhard I; Runnebaum B
Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
[TBL] [Abstract][Full Text] [Related]
39. Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses.
Hamilton MP; Abdalla HI; Whitfield CR
Obstet Gynecol; 1985 Apr; 65(4):465-70. PubMed ID: 2580253
[TBL] [Abstract][Full Text] [Related]
40. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
